Enanta Pharma (ENTA) Reports Q2 EPS of $1.49

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Enanta Pharma (ENTA) Reports Q2 EPS of $1.49

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2015

May 7, 2015 7:30 AM EDT

Conference Call and Webcast Today at 8:30 a.m. ET

Revenues for the quarter totaled $57.4 million

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today reported financial results for its fiscal second quarter ended March 31, 2015.

Fiscal Second Quarter Ended March 31, 2015 Financial Results

Cash, cash equivalents and short-term and long-term marketable securities totaled $226.8 million at March 31, 2015. This compares to a total of $131.8... More